Publications & Scientific Recognition

The HSR Patients App — developed by Swiss4ward for the Swiss Hidradenitis Suppurativa Foundation — was independently identified as one of only two patient-centred hidradenitis suppurativa apps worldwide in a systematic review published in JMIR mHealth and uHealth (2025, University Hospital Würzburg). The app is available in four languages across iOS and Android.

Swiss4ward's platforms have been used in peer-reviewed clinical research published in international journals. The QIVOM registry — a multi-centre clinical registry for intravitreal injection therapies developed with the University Medical Center Hamburg-Eppendorf (UKE) — was published in Die Ophthalmologie (Springer, 2022) with Swiss4ward named as technology partner.

Swiss4ward's platforms and technologies have been independently

referenced in peer-reviewed scientific publications and international

research projects. The following publications name Swiss4ward as

technology partner or platform develope— providing independent

validation of our clinical technology expertise.

Swiss4ward was named as technology partner in three scientific posters at the 51st Annual Meeting of the German Dermatological Society (DDG), published in JDDG (John Wiley & Sons, 2021). The posters covered three dermatological registries built on Swiss4ward's platform: HS-Best (hidradenitis suppurativa), PsoBest-Kids (juvenile psoriasis), and PP-Best (pustular psoriasis) — all operated in collaboration with the Institute for Health Services Research in Dermatology (IVDP) at UKE Hamburg-Eppendorf.